INS and type 1 diabetes mellitus: Despite improvements in hyperglycaemia, islet transplant recipients with longstanding type 1 diabetes that achieve insulin independence often ultimately require resumption of insulin; although this picture is complicated by functional effects of transplant medications on beta cell health [79].